Table 1.
Comparison of Anthropometric and Biochemical Characteristics in Polycystic Ovarian Syndrome Patients and Controls with Their Mean and Standard Deviations
S.No. | Parameter | Patients (n=204) | Controls (n=204) | p-Value |
---|---|---|---|---|
1 | Age (years) | 28±3.6 | 28±5.1 | 1.0000 |
2a | BMI (kg/m2) | 27.12±4.93 | 23.4±3.2 | <0.0001 |
3a | WC (inches) | 37±4.3 | 30.36±3.3 | <0.0001 |
4 | HC (inches) | 39.4±4.1 | 38.11±3.7 | 0.0008 |
5a | WHR | 0.93±0.04 | 0.79 0±05 | <0.0001 |
6 | Fasting glucose (mg/dL) | 88±8.6 | 86.85±7.1 | 0.0678 |
7a | Fasting insulin (μU/mL) | 16.94±7.26 | 6.66±3.19 | <0.0001 |
8a | HOMA score | 3.73±3.8 | 1.44±0.75 | <0.0001 |
9a | Serum TNF-α (pg/mL) | 13.24±10 | 5.5±3.8 | <0.0001 |
10a | Total Testosterone (ng/mL) | 5.8±4.319 | 1.32±1.05 | <0.0001 |
11a | Free Testosterone (ng/mL) | 8.39±6.69 | 2.6±1.4 | <0.0001 |
12a | Androstenedione (ng/mL) | 2.41±1.5 | 1.046±0.68 | <0.0001 |
13a | DHEA (ng/mL) | 6.22±5.66 | 1.9±0.99 | <0.0001 |
Significant values (p is <0.05).
BMI, body mass index; DHEA, dehydroxyepiandrostenedione; HC, hip circumference, HOMA score, homeostatic model assessment score; TNF-α, tumor necrosis factor alpha; WC, waist circumference; WHR, waist/hip ratio.